Novo Nordisk buys Akero Therapeutics in the US

Danish drugmaker Novo Nordisk NOVO_B said on Thursday it had agreed to buy United States based Akero Therapeutics, a clinical-stage company developing innovative treatments for patients with serious metabolic diseases marked by a high unmet medical need.